Frankfurt
23.07.25 | 08:10
1,760 Euro
-12,22 % -0,245
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Following the signature of a financial agreement for up to €37.5 million with the EIB, Median Technologies launches an approximately €22 million capital increase to support commercialization of eyonis LCS in the U.S. ... | 252 | Business Wire | Capital increase in the form of shares with attached warrants ("ABSA") without preferential subscription rights by way of an equity public offering and with a priority subscription period of 5... ► Artikel lesen | |
| 11.07. | Median Technologies Signs Financial Agreement for up to €37.5 Million New Financing Facility With the European Investment Bank (EIB) | 316 | Business Wire | Regulatory News:
Median Technologies FR0011049824, ALMDT, PEA-PME scheme eligible, "Median" or the "Company"), manufacturer of eyonis, a suite of artificial intelligence (AI) powered Software as... ► Artikel lesen | |
| 09.07. | Median Technologies: Half Year Liquidity Contract Statement | 234 | Business Wire | Regulatory News:
Under the liquidity contract entrusted by Median Technologies (PARIS: ALMDT, FR0011049824, ALMDT, PEA/SME eligible, "Median" or "the Company") to TP ICAP (Europe), the following... ► Artikel lesen | |
| 07.07. | Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of June 30, 2025 | 208 | Business Wire | Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations.
Regulatory News:
Median Technologies (Paris:ALMDT):
Total number of shares... ► Artikel lesen | |
| 01.07. | Median Technologies Files European Application for Class IIb CE Marking of Its AI-Based Software as a Medical Device for Lung Cancer Screening, eyonis LCS | 270 | Business Wire | Class IIb CE marking is a prerequisite for Median's eyonis LCS Software as a Medical Device marketing in Europe
Lung cancer screening programs are already implemented in several European... ► Artikel lesen | |
| 10.06. | Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of May 31, 2025 | 249 | Business Wire | Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations.
Regulatory News:
Median Technologies (Paris:ALMDT):
Total number of shares... ► Artikel lesen | |
| 28.05. | Median Technologies announces the availability of the preparatory documents for the Shareholders' Ordinary and Extraordinary General Meeting on June 17, 2025 | 354 | Business Wire | Regulatory News:
The shareholders of Median Technologies (FR0011049824, ALMDT, PEA/PME scheme eligible, "Median" or "The Company") are invited to participate in the Shareholders' Ordinary and Extraordinary... ► Artikel lesen | |
| 27.05. | Median Technologies to Showcase iCRO's Central and AI-Powered Imaging Services for Oncology Clinical Trials at ASCO 2025 | 266 | Business Wire | Median is a leading provider of imaging services to the world's top oncology pharma companies
ASCO abstracts position Median as highly differentiated provider of AI-imaging services for... ► Artikel lesen | |
| MEDIAN TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
| 16.05. | Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of April 30, 2025 | 305 | Business Wire | Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations.
Regulatory News:
Median Technologies (Paris:ALMDT):
Total number of shares
... ► Artikel lesen | |
| 14.05. | Median Technologies submits U.S. application for 510(k) clearance of eyonis LCS | 276 | Business Wire | Submission based on positive data from two pivotal studies, which both met their primary endpoints
U.S. clearance expected in Q3 2025 based on average observed review timelines for radiological... ► Artikel lesen | |
| 12.05. | Median Technologies to Present Scientific Posters on eyonis LCS in Two Major Health Conferences in North America in May 2025 | 272 | Business Wire | Projected economic benefits of using AI-powered detection/diagnostic Software as a Medical Device, like eyonis® LCS, will be presented at ISPOR 2025, the annual conference of the leading professional... ► Artikel lesen | |
| 06.05. | Median Technologies to Participate in Several Investor Conferences in May and June 2025 | 324 | Business Wire | Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, "Median" or the "Company"), manufacturer of eyonis, a suite of artificial intelligence (AI) powered Software... ► Artikel lesen | |
| 29.04. | Median Technologies Reports Full-year 2024 Financial Results | 388 | Business Wire | Returns to FY revenue growth in 2024 (+3.3%), with acceleration in H2 (+10.2%)
Slight decrease in operating loss, from €23.1 million in 2023 to €22.5 million in 2024
Operational... ► Artikel lesen | |
| 24.04. | Median Technologies Reports 2025 Q1 Key Financial Indicators and Provides an Update on Q1 Key Operational Achievements | 372 | Business Wire | €6.0 million in Q1 2025 revenues, up 11% over Q1 2024
€74.8 million all-time high order backlog as of March 31, 2025
eyonis LCS pivotal RELIVE study met all key endpoints
U.S.... ► Artikel lesen | |
| 07.04. | Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of March 31, 2025 | 196 | Business Wire | Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations.
Regulatory News:
Median Technologies (Paris:ALMDT):
Total number of shares
... ► Artikel lesen | |
| 31.03. | eyonis LCS, Median Technologies' AI-Powered Software as a Medical Device for Lung Cancer Screening, Confirmed Efficacy and Safety in RELIVE Pivotal Study | 317 | Business Wire | All secondary endpoints required to support eyonis LCS' intended use and desired marketing claims achieved in RELIVE
eyonis LCS previously met primary endpoint, achieving statistically... ► Artikel lesen | |
| 07.03. | Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of February 28, 2025 | 373 | Business Wire | Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations.
Regulatory News:
Median Technologies (Paris:ALMDT):
Total number of shares
... ► Artikel lesen | |
| 03.03. | Median Technologies Announces the Availability of the Preparatory Documents for the Shareholders' Extraordinary General Meeting on March 20, 2025 | 282 | Business Wire | Regulatory News:
The shareholders of Median Technologies (FR0011049824, ALMDT, PEA/PME scheme eligible, "Median" or "The Company") are invited to participate in the Shareholders' Extraordinary... ► Artikel lesen | |
| 26.02. | Median Technologies to Present at TD Cowen's 45th Annual Health Care Conference | 273 | Business Wire | Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA/SME eligible, "Median" or "The Company"), a leading developer of eyonis, a suite of artificial intelligence (AI) powered Software... ► Artikel lesen | |
| 24.02. | Median Technologies to Showcase Its Artificial Intelligence Software as a Medical Device for Lung Cancer Screening, eyonis LCS, at the European Congress of Radiology | 280 | Business Wire | Industry presentation at the AI Theatre: "eyonis LCS: Pioneering AI/ML Software as a Medical Device Redefining the Future of Lung Cancer Screening
Median eyonis teams will be at booth AI-18... ► Artikel lesen |
1 2 3 Weiter >>
42 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PALANTIR TECHNOLOGIES | 131,20 | +3,40 % | Märkte am Morgen: Friedrich Vorwerk, Bayer, Gerresheimer, Airbus, Coca-Cola, Nvidia, Palantir, Tesla | Muss Jerome Powell gehen oder nicht? Diese Frage hat gestern an den Aktienmärkten für Irritationen gesorgt. Donald Trump dementierte eine baldige Demission. Der DAX schloss trotzdem erneut in der Verlustzone.... ► Artikel lesen | |
| TEAMVIEWER | 9,570 | +0,16 % | TeamViewer SE: TeamViewer Q2-Vorschau: Aufwärtstrend dürfte anhalten; mwb research empfiehlt KAUFEN | TeamViewer (TMV) wird am 29. Juli seine Ergebnisse für das zweite Quartal veröffentlichen, wobei die Erwartungen auf eine Wiederholung der starken Leistung des ersten Quartals hindeuten. Der Umsatz... ► Artikel lesen | |
| ORACLE | 205,05 | +1,21 % | Groupe Mutuel wählt Oracle Fusion Cloud Applications Suite zur Optimierung der Abläufe und Förderung von Innovationen | Zürich - Das Westschweizer Versicherungsunternehmen Groupe Mutuel hat sich für die Oracle Fusion Cloud Applications Suite entschieden. Damit will das Unternehmen seine Finanz-, Beschaffungs- und HRProzesse... ► Artikel lesen | |
| SHOPIFY | 103,64 | -1,58 % | Märkte am Morgen: Bulle übernehmen wieder - Alzchem, Salzgitter, Netflix, PepsiCo, Shopify, Lucid | Drei Tage lang hat sich der DAX in dieser Woche schwergetan und jedes Mal im Minus geschlossen. Gestern schlug dann die Stunden der Bullen. Der DAX schloss deutlich im Plus und dürfte auch den heutigen... ► Artikel lesen | |
| CROWDSTRIKE | 392,15 | -2,19 % | Minimale Kursveränderung bei CrowdStrike-Aktie (406,5108 €) | Die Wertschätzung für die CrowdStrike-Aktie hat sich am Aktienmarkt heute kaum geändert. Zuletzt zahlten Investoren für das Wertpapier 473,02 US-Dollar. Kaum auffällig ist gegenwärtig an der Börse der... ► Artikel lesen | |
| D-WAVE QUANTUM | 17,200 | +14,93 % | D-Wave Quantum-Aktie: Geht's noch höher? | Die Hausse der D-Wave Quantum-Aktie geht in die nächste Runde. Der Kurs des kanadischen Quantencomputerherstellers steigt am Freitagmorgen auf 17 € und markiert damit ein neues Allzeithoch. Ist es für... ► Artikel lesen | |
| ZOOM COMMUNICATIONS | 64,45 | +0,72 % | DeepL expands real-time voice translation capabilities with new features and upcoming Zoom integration | New languages and productivity enhancements strengthen DeepL Voice as enterprise adoption accelerates worldwide
NEW YORK, July 23, 2025 /PRNewswire/ -- DeepL, a leading global Language... ► Artikel lesen | |
| ATOSS SOFTWARE | 139,60 | -0,71 % | Atoss Software: Investitionen von Unternehmen widerstandsfähig - Deutsche Banik | MÜNCHEN (IT-Times) - Analysten der Deutschen Bank haben sich zu Atoss Software in einem Research-Bereicht geäußert und das Kursziel für die Aktie angehoben. Die Deutsche Bank Research bestätigt in ihrem... ► Artikel lesen | |
| RIOT PLATFORMS | 12,062 | -0,56 % | Strategy vs. Riot Platforms: Which Bitcoin-Focused Stock Has an Edge? | ||
| VEEVA SYSTEMS | 243,80 | +0,41 % | Veeva Systems: Veeva OpenData and Veeva Network Enable Coordinated Customer Engagement for Boehringer Ingelheim | BARCELONA, Spain, July 23, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Boehringer Ingelheim is the latest top 20 biopharma to standardize customer data across more than... ► Artikel lesen | |
| FASTLY | 6,132 | +0,43 % | Fastly-CEO tritt nach kurzem Gastspiel überraschend zurück | SAN FRANCISCO, Kalifornien (IT-Times) - Fastly hat eine personelle Veränderung im Top-Management des Unternehmens bekannt gegeben. Der CEO des Unternehmens tritt zurück. Fastly Inc. (NYSE: FSLY, ISIN:... ► Artikel lesen | |
| BRAINCHIP | 0,123 | +2,16 % | BRAINCHIP HOLDINGS LTD: Notification regarding unquoted securities - BRN | ||
| GEN DIGITAL | 26,200 | +0,77 % | P/E Ratio Insights for Gen Digital | ||
| ATLASSIAN | 171,64 | +1,67 % | Atlassian-Aktie mit Kursgewinnen (172,1519 €) | Im Plus liegt gegenwärtig die Aktie von Atlassian . Zuletzt zahlten Investoren für die Aktie 201,49 US-Dollar. Ein Wertanstieg von 3,71 Prozent steht gegenwärtig für die Atlassian-Aktie zu Buche. Das... ► Artikel lesen | |
| VERSES AI | 5,490 | -1,44 % | Verses AI Inc (3): Verses AI to hold webinar on July 29 |
Das Unternehmen MEDIAN TECHNOLOGIES kann der Branche Software zugeordnet werden. Mit einer aktuellen Kursveränderung von -0,245 (-12,22 %) liegt der Kurs bei 1,760 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MEDIAN TECHNOLOGIES finden Sie auf Wallstreet Online.